Nimesulide in the treatment of osteoarthritis
Osteoarthritis (OA) is the most common joint disorder among the world’s population. It is costly and a major cause of pain and disability, especially in the elderly. The main aims of pharmacotherapy for OA are to provide pain relief, reduce inflammation, maintain movement and to positively affect...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Publiediting
2005-05-01
|
| Series: | Pathos |
| Subjects: | |
| Online Access: | http://www.pathos-journal.com/doc/2005_1-2_RassegnaNimesulide_Bianchi.pdf |
| Summary: | Osteoarthritis (OA) is the most common joint disorder among the
world’s population. It is costly and a major cause of pain and disability, especially in the elderly. The main aims of pharmacotherapy for OA are to provide pain relief, reduce
inflammation, maintain movement and to positively affect the natural course of this disease by reducing the degradation
of joint cartilage. The severity of pain often prompts treatment with nonsteroidal anti-inflammatory drugs (NSAIDs), which are commonly used. Many patients with symptomatic OA cannot
manage without them. World-wide experience with nimesulide
confirms that it is a NSAID with good analgesic efficacy and a number of pharmacological properties that may result particularly favourable in the treatment of joint diseases. In the last few years several controlled studies have been done in order to investigate
its effects in patients with OA. The objective of this review is to deal with some aspects concerning the main features of OA and to point out the role of nimesulide as a drug particularly effective in the treatment of this disease. |
|---|---|
| ISSN: | 1593-2354 1593-2354 |